本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (5517)
All Articles published online
|
Publishing Process of This Article
|
2018-09-08 (publication date) through 2024-11-09
本文章的被引频次
本文章的期刊信息
出版物名称
世界华人消化杂志
ISSN
1009-3079
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 沈彬, 尹浩, 朱晓萍, 肖卫星, 周君, 肖广远, 周海军. 腹腔镜下胆囊切除术辅用消炎利胆片对急性胆囊炎患者术后疗效、预后及血清学指标变化的分析. 世界华人消化杂志 2018; 26(25): 1523-1528 [DOI: 10.11569/wcjd.v26.i25.1523] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v26/i25/1523.htm |
| 编号 | Citing Articles |
| 1 |
Meiqi Wang, Fangle Liu, Yufeng Yao, Qiuyu Zhang, Zenghui Lu, Runjing Zhang, Changhui Liu, Chaozhan Lin, Chenchen Zhu. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats. Journal of Ethnopharmacology 2021; 270: 113816 doi: 10.1016/j.jep.2021.113816
|
| 2 |
Kaihui Zhang, Meiqi Wang, Yufeng Yao, Tao Huang, Fangle Liu, Chenchen Zhu, Chaozhan Lin. Pharmacokinetic study of seven bioactive components of Xiaoyan Lidan Formula in cholestatic and control rats using UPLC-MS/MS. Biomedicine & Pharmacotherapy 2021; 139: 111523 doi: 10.1016/j.biopha.2021.111523
|
| 3 |
Runjing Zhang, Tao Huang, Qiuyu Zhang, Yufeng Yao, Changhui Liu, Chaozhan Lin, Chenchen Zhu. Xiaoyan lidan formula ameliorates α-naphthylisothiocyanate-induced intrahepatic cholestatic liver injury in rats as revealed by non-targeted and targeted metabolomics. Journal of Pharmaceutical and Biomedical Analysis 2020; 179: 112966 doi: 10.1016/j.jpba.2019.112966
|
| 4 |
Dafu Tang, Wanyu Hu, Bingxuan Fu, Xiaojie Zhao, Guoquan You, Cong Xie, Hong Yu Wang, Xueni Guo, Qianbing Zhang, Zhongqiu Liu, Ling Ye. Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2387402
|